期刊
CURRENT NEUROPHARMACOLOGY
卷 4, 期 2, 页码 139-147出版社
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/157015906776359577
关键词
Alzheimer's disease; neuronal death; amyloid beta; amyloid precursor protein (APP); presenilin (PS); humanin(HN); neuroprotection
Brain atrophy caused by neuronal loss is a prominent pathological feature of Alzheimer's disease (A beta). Amyloid beta (beta D), the major component of senile plaques, is considered to play a central role in neuronal cell death. In addition to removal of the toxic A beta, direct suppression of neuronal loss is an essential part of AD treatment; however, no such neuroprotective therapies have been developed. Excess amount of A beta evokes multiple cytotoxic mechanisms, involving increase of the intracellular Ca2+ level, oxidative stress, and receptor-mediated activation of cell-death cascades. Such diversity in cytotoxic mechanisms induced by A beta clearly indicates a complex nature of the AD-related neuronal cell death. We have identified a 24-residue peptide, Humanin (HN), which suppresses in vitro neuronal cell death caused by all AD-related insults, including A beta, so far tested. The anti-AD effect of HN has been further confirmed in vivo using mice with A beta-induced amnesia. Altogether, such potent neuroprotective activity of HN against AD-relevant cytotoxicity both hi vitro and in vivo suggests the potential clinical applications of HN in novel AD therapies aimed at controlling neuronal death.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据